Dr. Nadiesda Costa, MD

Dr. Costa practices at Medstar Georgetown Medical Center in Washington, District of Columbia.

Dr. Costa's NPI, 1457335895, was assigned on November 30, 2005. Dr. Costa graduated from Universidad Autonoma de Santo Domingo in 1998. Dr. Costa holds Maryland license D74923.

Dr. Costa's primary practice is Medstar Georgetown Medical Center, at 3800 Reservoir NW Rd, Washington, DC 20007 in District Of Columbia County. The practice phone is (202) 444-1400.

Dr. Costa's primary practice is Medstar Georgetown Medical Center in Washington, District of Columbia. Dr. Costa is also affiliated with MedStar Washington Hospital Center. The medical group on file is MedStar Medical Group. Dmand AI also links Dr. Costa to 2 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Costa practices, 3 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Costa's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Costa is licensed in Maryland.

CMS data shows 911 Medicare services from Dr. Costa across 5 procedure codes in 2024, for 276 Medicare patients. Medicare paid $109,470 for them.

CMS counts 276 Medicare patients who saw Dr. Costa in 2024. The largest group is under 65, with 150 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 27% are also on Medicaid. Their average risk score is 6.44, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Costa's median patient age at 59, with 36% women.

In 2024, Dr. Costa wrote 351 Medicare Part D claims for 100 patients. 92% of them were for generic drugs. CMS names the drug for 223 of them, across 10 drugs with 11 or more claims each, at $33,252 in total drug cost. In 2023, CMS named 111 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Costa for performance year 2024, reported as part of a group. Dr. Costa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Costa as offering telehealth.

Dmand AI links 10 papers to Dr. Costa, published from 2011 to 2025. 2017 was the busiest year, with 2. The most frequent topics are Kidney Transplantation, Postoperative Complications and Glomerular Filtration Rate. Dr. Costa has published most often in Am J Transplant. Dr. Costa's most frequent co-authors are Jonathan Scott Bromberg, MD, Abdolreza Haririan, MD and David Black Leeser, MD.

CMS Open Payments shows 21 general payments to Dr. Costa from 13 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 58% of the total. Calliditas Therapeutics US Inc. paid the most, $2,500.

Dmand AI lists 1 award for Dr. Costa, most recently Young Investigator in 2012.

Dr. Costa graduated from Universidad Autonoma de Santo Domingo in 1998.

Dr. Costa is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and CareFirst BlueCross BlueShield. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.